ESK-001, a novel therapy for moderate to severe plaque psoriasis, had acceptable safety and efficacy outcomes at 12 weeks of treatment.

Clinician documentation concerning patient credibility disproportionately undermined Black individuals vs patients of other races.

Topline results were announced from a phase 3 trial evaluating Cylembio (imsapepimut and etimupepimut, adjuvanted) in combination with pembrolizumab as a first-line treatment for advanced melanoma.

Wait times for a bed exceeding 4 hours occurred in 25% of admissions from the emergency room in nonpeak months.

The use of products contaminated with B. cepecia may result in local infections and possibly more serious infections in immunocompromised individuals.

Patients with dermally-based leiomyosarcoma generally have a better prognosis than patients with subcutis-based leiomyosarcoma.

The Gates Foundation will fund $2.5 billion in research on gynecological and obstetric care, contraceptives, STIs, and maternal health.

Patients' perceptions of physician professionalism, trust, and communication are dependent on physician dress and context.